In addition, a high pretreatment RDW in patients with breast cancer was associated with poor overall and disease-free survival, along with a large tumor size, a high rate of lymph node metastases, tumor stage, advanced stage, a higher lymphocyte count, and high fibrinogen and CRP levels [28]. The gene discussed is CRP; the disease is breast cancer.